New Studies

Major findings from Lancet, BMJ, NEJM, JAMA, and other leading journals

Monoclonal antibody cliramitug shows sustained benefit in cardiac amyloidosis over 29 months

Long-term follow-up of the NI006-101 trial shows that cliramitug, a monoclonal antibody targeting misfolded transthyretin, sustains clinical benefit in cardiac…

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.

More form New Studies

How Muscle Really Grows: Exercise Triggers Protein Synthesis, Not Just Microscopic Tears

Research now shows that muscle growth is driven primarily by elevated protein synthesis triggered by…